8-K filed May 28, 2026, 4:35 PM ET ticker ISRG CIK 0001035267

leadership confidence high sentiment neutral materiality 0.55

Intuitive Surgical names Taylor Patton CCO, Henry Charlton moves to SVP Global Business Ops

INTUITIVE SURGICAL INC

Taylor Patton promoted to Chief Commercial and Marketing Officer, effective July 1, 2026.
Henry Charlton transitions to SVP of Global Business Operations after serving as CCO.
Patton previously led Intuitive's Ion platform launch as Global SVP of Endoluminal.
Charlton has been with Intuitive since 2003; will support smooth transition.
Patton joins Executive Leadership team; Charlton will focus on global value generation.

item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001035267-26-000042
form_type: 8-K
ticker: ISRG
cik: 0001035267
company_name: INTUITIVE SURGICAL INC
filed_at: 2026-05-28T20:35:49+00:00
discovered_at: 2026-05-28T20:37:00.906167+00:00
generated_at: 2026-05-28T20:39:52.309751+00:00
sec_items: ["5.02", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001035267-26-000042
json_url: https://secwatch.observer/filing/0001035267-26-000042.json
markdown_url: https://secwatch.observer/filing/0001035267-26-000042.md
text_url: https://secwatch.observer/filing/0001035267-26-000042.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000042/0001035267-26-000042-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1035267/000103526726000042/isrg-20260528.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Taylor Patton

Chief Commercial and Marketing Officer

ISRG · INTUITIVE SURGICAL INC

Effective: 2026-07-01
Filed: May 28, 2026, 4:35 PM ET

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Role change

Henry L. Charlton

Senior Vice President of Global Business Operations

ISRG · INTUITIVE SURGICAL INC

Effective: 2026-07-01
Successor: Taylor Patton
Filed: May 28, 2026, 4:35 PM ET

Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.

Source-grounded claims

bf05ed79ea

Taylor Patton was appointed as Chief Commercial and Marketing Officer at INTUITIVE SURGICAL INC.

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

c5a8d80b01

Henry L. Charlton changed role as Senior Vice President of Global Business Operations at INTUITIVE SURGICAL INC.

Effective July 1, 2026, Henry L. Charlton will transition from his role as Chief Commercial and Marketing Officer of Intuitive Surgical, Inc. (the “Company”) and begin serving as Senior Vice President of Global Business Operations of the Company.

SEC 8-K Item 5.02 confidence 0.95 SEC evidence

Comparable filings

MGNO

Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair

Magnolia Bancorp, Inc. June 1, 2026, 2:15 PM ET leadership Items 5.02, 5.07, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.

Filing page SEC filing

FSBW

FS Bancorp names Matt Mullet CEO as planned; Joe Adams retires but stays on board

FS Bancorp, Inc. June 1, 2026, 11:31 AM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

it has named Matthew D. Mullet as Chief Executive Officer of the Company effective June 1, 2026

Filing page SEC filing

NSC

Norfolk Southern COO John Orr resigns; Brian Barr appointed successor effective June 1

NORFOLK SOUTHERN CORP June 1, 2026, 9:15 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

On May 31, 2026, John Orr, Executive Vice President & Chief Operating Officer of Norfolk Southern Corporation (the “Company”), notified the Company of his intention to resign from the Company for “good reason” on account of proposed changes in the Company’s operations that would result in a diminution of his duties and responsibilities.

Filing page SEC filing

BTBD

BT Brands CFO Kenneth Brimmer resigns; no successor named

BT Brands, Inc. June 1, 2026, 8:56 AM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

Effective May 26, 2026, Kenneth Brimmer resigned from his positions as a member of the Board of Directors and Chief Financial Officer of BT Brands, Inc.

Filing page SEC filing

FUSE

Fusemachines appoints AI pioneer Dr. Julia Hirschberg to board; Shrestha resigns

Fusemachines Inc. June 1, 2026, 8:18 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

Effective May 31, 2026, the board of directors (the “Board”) of Fusemachines Inc., a Delaware corporation (the “Company” or “Fusemachines”), following the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), appointed Julia Hirschberg as a member of the Board as a Class II director, until the Company’s 2027 annual meeting of stockholders or until Ms. Hirschberg’s successor is duly elected and qualified.

Filing page SEC filing

SNDA

Sonida Senior Living appoints Anton Nikodemus as COO effective June 15, 2026; base salary $550,000

SONIDA SENIOR LIVING, INC. June 1, 2026, 8:09 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

On June 1, 2026, the Board of Directors (the “Board”) of Sonida Senior Living, Inc. (the “Company”) appointed Anton Nikodemus as Executive Vice President and Chief Operating Officer of the Company, effective June 15, 2026.

Filing page SEC filing

Carlyle appoints Kate Heinzelman as General Counsel; Jeff Ferguson to be Senior Advisor

Carlyle Group Inc. June 1, 2026, 8:00 AM ET leadership Items 5.02, 7.01, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

Mr. Ferguson will become a Senior Advisor to Carlyle

Filing page SEC filing

BCBP

BCB Bancorp appoints Thomas M. O'Brien as President & CEO effective June 1, 2026

BCB BANCORP INC June 1, 2026, 8:00 AM ET leadership Items 5.02, 9.01

same fact type: executive_change same SEC item: 5.02, 9.01 same event type: leadership similar materiality

This filing

Taylor Patton, Global Senior Vice President, Endoluminal will succeed Mr. Charlton as the Company’s Chief Commercial and Marketing Officer.

Comparable filing

Thomas M. O'Brien has been appointed as the President and Chief Executive Officer of the Company and the Bank, effective June 1, 2026.

Filing page SEC filing

Source: SEC EDGAR

accession 0001035267-26-000042

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.